Topical Androgen Receptor Inhibitors Market Size

Topical Androgen Receptor Inhibitors Market size is anticipated to reach USD 221.8 Million by the end of 2036, growing at a CAGR of 14% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of topical androgen receptor inhibitors was USD 40 Million. The need for potent topical androgen receptor inhibitors is driven by the increasing incidence of androgenetic alopecia and hirsutism, two disorders associated with androgen receptors. AGA is becoming more commonplace worldwide because of a combination of lifestyle, hormone fluctuations, and genetics. A greater number of patients are seeking effective treatments, such as topical androgen receptor inhibitors, as a result of this rising incidence. Excessive hair growth in women, frequently with a male pattern, is a symptom of hirsutism. Hormonal imbalances and conditions such as polycystic ovarian syndrome (PCOS) can aggravate hirsutism. Data from the World Health Organization (WHO) in June 2023 indicate that 8–13% of women of reproductive age have PCOS. Worldwide, up to 70% of afflicted women go undetected.

People are looking for ways to control their undesired hair growth as awareness of these conditions increases, which is driving up demand for topical androgen receptor inhibitors. The increasing prevalence of androgen-related conditions is a significant growth factor for the topical androgen receptor inhibitors market.